FDA approves first drug to treat hallucinations and delusions associated with Parkinson's disease

The U.S. Food and Drug Administration has approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some...
Source: Parkinson's Disease News From Medical News Today - Category: Neurology Tags: Parkinson's Disease Source Type: news